NRXP

NRx Pharmaceuticals (NRXP)

About NRx Pharmaceuticals (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high

$3.42

Daily low

$2.89

Price at open

$3.39

52 Week High

$3.84

52 Week Low

$1.62

Market cap

108.5M

Dividend yield

0.00%

Volume

2.0M

Avg. volume

1.3M

P/E ratio

-2.09

NRx Pharmaceuticals News